Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2026-02-27 @ 3:50 PM
Study NCT ID:
NCT01263704
Status:
COMPLETED
Last Update Posted:
2018-04-23
First Post:
2010-12-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of MabThera/Rituxan (Rituximab) in Combination With Fludarabine And Cyclophosphamide as Primary Therapy in Elderly Patients With Chronic Lymphocytic Leukemia
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-07-17
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-12-17
First Submit QC Date:
None
Study First Post Date:
2010-12-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-19
Results First Submit QC Date:
None
Results First Post Date:
2018-04-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-18
Last Update Post Date:
2018-04-23
Last Update Post Date Type:
ACTUAL